Home LiteratureArticle Details
PMID: 24720539 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcription.

Current molecular pharmacology ·Vol. 6 ·No. 3 ·2013-11-00 ·Pages 204-10

Kida A, Kahn M

Abstract

Hypoxia has been reported to regulate both stem cell maintenance and differentiation. Wnt signaling is also a key regulator in stem cells. The recent discovery of functional cross-regulation between the Wnt pathway and HIF-1α/HIF-2α signaling further highlights the complexity of the role of hypoxia in the regulation of stem cells. In this report we reveal that human CML cell lines treated under hypoxic conditions increase the percentage of leukemia stem/initiating-like cells, as judged by surface marker expression, colony forming ability and quiescence. We demonstrate that differential usage of the Kat3 coactivators, CREBBP/Creb Binding Protein (CBP) and EP300 (p300) by catenin, with increased CBP/catenin signaling at the expense of p300/catenin signaling, is mechanistically correlated with the increase in the leukemia stem/initiating-like population. A specific small molecule inhibitor of CBP/catenin dependent transcription, ICG-001, can reverse these effects further demonstrating the critical involvement of CBP/catenin signaling in enhancing and maintaining the leukemia stem/initiating-like cell population under hypoxic conditions.

MeSH Terms
CREB-Binding Protein/genetics,metabolism Catenins/genetics Cell Differentiation Cell Hypoxia Cell Line, Tumor Cell Proliferation Cell Survival Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics,metabolism,pathology Oxygen/metabolism Transcriptional Activation Wnt Signaling Pathway
Chemicals
Catenins CREB-Binding Protein Oxygen
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kida Aiko
Kahn Michael
University of Southern California, 1450 Biggy Street, NRT 4501, Los Angeles, CA 90033, USA. kahnm@usc.edu.
Article Info
Journal
Current molecular pharmacology
Abbr.
Curr Mol Pharmacol
ISSN
1874-4702
Published
2013-11-00
Pages
204-10
Language
English
Region
United Arab Emirates
NLM ID
101467997
Subset
IM
Grants
NCI NIH HHS · P30 CA014089 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com